November 23, 2020
Predictors of Late Effects in Young AML Survivors Explored
MONDAY, Nov. 23, 2020 (HealthDay News) — Many adolescent and young adult (AYA) survivors of acute myeloid leukemia (AML) experience late effects, with the most common being endocrine, cardiovascular, and respiratory, according to a study published online Nov. 9 in the International Journal of Epidemiology. Renata Abrahão, M.D., Ph.D., from the University of California Davis...